
Fausto Pinto
@fjpinto1960
Diretor do Serviço de Cardiologia do CHULN; Past-President, World Heart Federation,
ID: 43507476
http://faustopinto.com 30-05-2009 09:35:38
5,5K Tweet
3,3K Followers
1,1K Following






Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis #Colchicine significantly reduced #MACE in patients with vascular disease: pooled HR 0.75 (95% CI 0.56–0.93) across 6 RCTs (n=21,800). academic.oup.com/eurheartj/adva… #EHJ EHJ Editor-in-Chief European Society of Cardiology Journals


Long-term trials of colchicine for secondary prevention of vascular events. Discover the results of a meta-analysis just published in #EHJ 👉 ow.ly/uJgm50VNwLE Rocco Montone EHJ Editor-in-Chief #prevention #colchicine




Efficacy of Colchicine in Reducing Major Adverse Cardiovascular Events: a Meta-Analysis of Randomized Controlled Trials! academic.oup.com/eurheartj/adva… #EHJ #cardiotwitter #colchicine #ischaemia #stroke @ESC_journals European Society of Cardiology




Starting the World Heart Forum World Heart Federation in Geneva, on Coronary artery disease in women.


At our WHF Forum on Coronary Disease in Women, WHF Past President Fausto Pinto, Yubrine M.Gachemba MD. (MBChB,MMed, PgDip,MSc.), and Rick Chazal, MD MACC just discussed the latest innovations in improving the diagnosis and treatment of women with cardiovascular disease, such as biomarkers and imaging techniques.


Fantastic panel on “My story: The lived experience” where we heard amazing real life stories. Thank you for sharing. Great discussion. World Heart Federation Jagat Narula Dorairaj Prabhakaran


Honored to join Fausto Pinto and Rick Chazal, MD MACC at the #WHFForum to spotlight innovations that are reshaping how we diagnose and treat cardiovascular disease in women—from biomarkers to cutting-edge imaging. The future of heart health is precise, inclusive, and powered by science.



The American Heart Association just published their alcohol recommendations today which line up with the report by the National Academies. Moderate EtOH intake, up to 7 drinks per week (1/day), is without risk (and may be beneficial for cardiovascular outcomes) American Heart Association
